Thomas Garrity Net Worth & Insider Trades

Thomas Garrity - Director, Antares Pharma, Inc

As of June 14, 2021

What is Thomas Garrity's Net Worth?

The current estimated net worth of Antares Pharma, Inc's Director, Thomas Garrity, is estimated to be about $2.57M . Thomas Garrity owns about 160,213 units of Antares Pharma, Inc common stock. In the last 9 years at Antares Pharma, Inc, Thomas Garrity has sold an estimated value of $244.48K worth.

What is Thomas Garrity's Past Insider Trading?

Thomas Garrity's largest purchase order was 30,000 units , worth over $21.6K on March 21, 2016. Thomas Garrity's largest sale order was 31,000 units , worth over $124.47K on August 22, 2012. In total, Thomas Garrity has made about 11 transactions over 9 years of their time at Antares Pharma, Inc. Thomas Garrity usually trades in June, with the busiest year in 2012.

Thomas J Garrity

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What are Antares Pharma, Inc's Past Insider Trades?

Antares Pharma, Inc's most recent insider trade came on July 9, 2021 by Anton Gueth who sold 100,000 units worth $429K . In the last 9 years, insiders at Antares Pharma, Inc have sold an estimated value of $74.16M and bought an estimated value of $14.77M worth of shares. Insider trading is most common in June, with the busiest year in 2018. The most active traders at the company are Robert F Apple, President and CEO,  Jacques Gonella, Director,  and Leonard S Jacob, Director .

ANTARES PHARMA, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...